ISSDP

The International Society for the Study of Drug Policy

The International Society for the Study of Drug Policy

  • Conferences & Events
    • Future Conferences & Events
    • Past Conferences & Events
    • United Nations Commission of Narcotics Drugs
    • Webinars
  • News and Announcements
    • Current News & Announcements
    • Newsletters
    • Archived News & Announcements
  • Bibliography
    • Introduction
    • All Publications
    • Bibliography Archive
    • Prevalence
    • Production and Supply
    • Economics
    • Domestic Policy Issues
    • International Policy Issues
    • Interventions – Prevention
    • Interventions – Treatment
    • Interventions – Law Enforcement
    • Interventions – Harm Reduction
  • Membership
  • Who we are
  • Working Group
  • By-laws
  • Annual Awards
  • IJDP

Bibliography: Prevalence


Opioid- and Stimulant-related Harms in Canada

29th March 2023

Presented here are the most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to September 2022 in Canada, where available (Government of Canada)

Categories: Bibliography, Prevalence

Categories: Prevalence

Wastewater samples from over 100 European cities reveal latest drug-taking trends

23rd March 2023

The latest findings from the largest European project in the science of wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study (EMCDDA)

Categories: Bibliography, International Policy Issues, Prevalence

Categories: International Policy Issues, Prevalence

Global Report on Cocaine 2023

22nd March 2023

UNODC

Categories: Bibliography, International Policy Issues, Prevalence, Production and Supply

Categories: International Policy Issues, Prevalence, Production and Supply

Report 18 of the National Wastewater Drug Monitoring Program

15th March 2023

Report 18 of the National Wastewater Drug Monitoring Program covered sampling in August and October 2022. In August, 58 wastewater sites were monitored nationally, covering approximately 57% of the Australian population Download report

Categories: Bibliography, Prevalence

Categories: Prevalence

Youth Risk Behavior Survey Data Summary & Trends Report: 2011–2021

3rd March 2023

Provides the most recent surveillance data, as well as 10-year trends, on health behaviours and experiences among high school students in the United States (U.S.) related to adolescent health and well-being (CDC)

Categories: Bibliography, Prevalence

Categories: Prevalence

Hepatitis C in the UK 2023

3rd February 2023

Working to eliminate hepatitis C as a public health threat (Health Security Agency)

Categories: Bibliography, Interventions - Harm Reduction, Interventions - Prevention, Interventions - Treatment, Prevalence

Categories: Interventions - Harm Reduction, Interventions - Prevention, Interventions - Treatment, Prevalence

Substance misuse treatment for young people: statistics 2021 to 2022

3rd February 2023

Alcohol and drug treatment data for young people under 18, from the National Drug Treatment Monitoring System (Office for Health Improvement and Disparities)

Categories: Bibliography, Interventions - Treatment, Prevalence

Categories: Interventions - Treatment, Prevalence

Opioids Prescribed to Adults at Discharge From Emergency Departments: United States, 2017–2020

20th January 2023

Opioids may be an effective treatment for chronic and acute pain when properly used (1). However, receiving an opioid prescription in the emergency department (ED) has been identified as a potential risk factor for long-term use (CDCX)

Categories: Bibliography, Prevalence

Categories: Prevalence

Substance misuse treatment for adults: statistics 2021 to 2022

20th January 2023

Statistics on alcohol and drug misuse treatment for adults from the National Drug Treatment Monitoring System (NDTMS)

Categories: Bibliography, Interventions - Treatment, Prevalence

Categories: Interventions - Treatment, Prevalence

SAMHSA Announces National Survey on Drug Use and Health (NSDUH) Results Detailing Mental Illness and Substance Use Levels in 2021

5th January 2023

The 2021 NSDUH national report includes selected estimates by race, ethnicity, and age group. It is the most comprehensive report on substance use and mental health indicators that SAMHSA has released to date

Categories: Bibliography, Prevalence

Categories: Prevalence

Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2021

15th December 2022

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary (SAMHSA)

Categories: Bibliography, Interventions - Treatment, Prevalence

Categories: Interventions - Treatment, Prevalence

Drug and alcohol services – co-occurring substance use and mental health concerns: literature and evidence review

2nd December 2022

This report provides a rapid review of the literature on co-occurring substance use and mental health concerns and the integration of mental health and substance use services in Scotland (Scottish Government)

Categories: Interventions - Harm Reduction, Interventions - Treatment, Prevalence

HIV Action Plan monitoring and evaluation framework

2nd December 2022

The 2021 data has shown positive signs of recovery, but that recovery is uneven. The number of all people with diagnosed HIV infection and in care who were treated and virally suppressed remained extremely high between 2019 and 2021 (UK Government)

Categories: Bibliography, Interventions - Harm Reduction, Interventions - Treatment, Prevalence

Categories: Interventions - Harm Reduction, Interventions - Treatment, Prevalence

Trends in the availability and types of drugs sold on the internet via cryptomarkets, October 2021 – September 2022

1st December 2022

This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period (a new bulletin is released typically every four months). The current bulletin focuses on analysis of drug listings on cryptomarkets from 1 October 2021 to 30 September 2022 (NDARC)

Categories: Bibliography, Prevalence, Production and Supply

Categories: Prevalence, Production and Supply

Drug Overdose Deaths in Adults Aged 65 and Over: United States, 2000–2020

30th November 2022

Between 2000 and 2020, age-adjusted rates of drug overdose deaths for adults aged 65 and over increased from 2.4 to 8.8 deaths per 100,000 standard population (CDC)

Categories: Bibliography, Prevalence

Categories: Prevalence

Drug-Related and Drug-Misuse Deaths 2011-2021

25th November 2022

The 2011-2021 edition of Drug-related and drug-misuse deaths contains a revised version of drug-misuse deaths which makes data for Northern Ireland comparable with England and Wales

Categories: Bibliography, Prevalence

Categories: Prevalence

Deaths of homeless people in England and Wales: 2021 registrations

24th November 2022

Almost two in five deaths of homeless people were related to drug poisoning in 2021 (259 estimated deaths; 35.0% of the total number), consistent with previous years (ONS)

Categories: Bibliography, Prevalence

Categories: Prevalence

Drug-related hospital statistics – Scotland 2021 to 2022

23rd November 2022

This release by Public Health Scotland (PHS) presents information on hospital activity relating to illicit drug use in Scotland during the period 1996/97 to 2021/22. The topics covered include: the number of hospital stays, the number and characteristics of patients, substances used and geographical variations. These data are published in a dashboard and full report

Categories: Bibliography, Interventions - Treatment, Prevalence

Categories: Interventions - Treatment, Prevalence

Recreational use of nitrous oxide — a growing concern for Europe

21st November 2022

The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe (EMCDDA)

Categories: Bibliography, Prevalence

Categories: Prevalence

Scottish Health Survey 2021 published

9th November 2022

Three percent of adults reported ever having a problem with drugs. Twelve per cent of adults reported using drugs in the previous 12 months. Prevalence was highest amongst those aged 16-24 (22%) (Scottish Government)

Categories: Bibliography, Prevalence

Categories: Prevalence

Estimated numbers of people prescribed opioid substitution therapy in Scotland

9th November 2022

In 2021/22, Opioid Substitution Therapy (OST) was prescribed to an estimated minimum of 29,600 people in Scotland. This was a small increase compared to the 2020/21 estimate (29,416) (Public Health Scotland)

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Results and challenges of running the Web Survey on Drugs in Luxembourg: a major contribution to understanding the drug situation

7th November 2022

This paper shows how the second wave of the European Web Survey on Drugs (EWSD) led to a better understanding of the drug situation in Luxembourg. Until the EWSD, detailed information on the drug situation in Luxembourg was very limited, with only a few surveys, often small-scale, having been conducted in the country since the late 1990s (EMCDDA)

Categories: Bibliography, International Policy Issues, Prevalence

Categories: International Policy Issues, Prevalence

New report finds 171 drug-related hospitalisations per day in Australia in 2020-21

3rd November 2022

There were 62,486 drug-related hospitalisations (excluding alcohol and tobacco) among Australians in 2020-21, according to a new report released today by the Drug Trends program at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney

Categories: Bibliography, Prevalence

Categories: Prevalence

Harm Reduction Database Wales: Drug related mortality

28th October 2022

Annual Report 2021-22 – PowerPoint (Public Health Wales)

Categories: Bibliography, Prevalence

Categories: Prevalence

New report finds 171 drug-related hospitalisations per day in Australia in 2020-21

27th October 2022

There were 62,486 drug-related hospitalisations (excluding alcohol and tobacco) among Australians in 2020-21, according to a new report released today by the Drug Trends program at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney

Categories: Bibliography, Prevalence

Categories: Prevalence

Wales’ drug deaths a complex picture

20th October 2022

A complex and evolving pattern of drug use and availability is resulting in increased drug deaths in Wales, with two thirds of deaths in 2021 involving a combination of drugs, including alcohol and prescription medicines Download (Public Health Wales)

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Problematic opioid use in Ireland, 2015–2019

13th October 2022

In this report, we present the results of a study that aimed to estimate the prevalence of problematic opioid use in Ireland from 2015 to 2019 using a four-source capture-recapture method. Three of the four data sources used for the analysis were derived from opioid substitution treatment records from the Central Treatment List (CTL) (clinics, general practitioners (GPs) and prisons) and the fourth data source was derived from the Probation Service (HRB National Drugs Library)

Categories: Bibliography, Prevalence

Categories: Prevalence

New Report Recommends 34 Indicators to Improve Measuring the Impact of Drug-Impaired Driving Across Canada

30th September 2022

A new report released today by the Canadian Centre on Substance Use and Addiction (CCSA) recommends 34 indicators (e.g., collecting anonymous data on the potential presence and types of drugs in hospitalized drivers) to better measure the impact of DID across Canada

Categories: Bibliography, Prevalence

Categories: Prevalence

Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews

27th September 2022

his includes:

A report overviewing the key findings in 2022;
An infographic summarising key findings in 2022;
A methods document highlighting approaches to collating and presenting estimates; and
The executive summary, summarising key findings in 2022.

Categories: Bibliography, Prevalence

Categories: Prevalence

Smoking, Drinking and Drug Use among Young People in England, 2021

7th September 2022

This report contains results from the latest survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15), focusing on smoking, drinking and drug use. It covers a range of topics including prevalence, habits, attitudes, and wellbeing (NHS)

Categories: Bibliography, Prevalence

Categories: Prevalence

Australia’s Annual Overdose Report

31st August 2022

Penington Institute publishes Australia’s Annual Overdose Report, the most comprehensive and ambitious study of overdose in Australia

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Scottish Drug Deaths Taskforce Evidence Paper

25th August 2022

The evidence presented and summarised in this paper is split into sections on topics relevant to the research and evidence gathered in preparation for our final report Changing Lives (Deaths Taskforce)

Categories: Bibliography, Prevalence

Categories: Prevalence

Delving deeper into the social health of people who use methamphetamine

24th August 2022

A large 2019 survey estimated that 300,000 Australians aged 14 years and over had used some form of illicit meth/amphetamine in the previous year. Half had used the crystal form of methamphetamine (“ice”), and one-fifth had used the powdered form “speed” (Monash University)

Categories: Bibliography, Prevalence

Categories: Prevalence

People who inject drugs: HIV and viral hepatitis monitoring

12th August 2022

Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (UK Health Security Agency)

Categories: Bibliography, Prevalence

Categories: Prevalence

European Drug Report 2022: Trends and Developments

5th August 2022

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)

Categories: Bibliography, International Policy Issues, Prevalence, Production and Supply

Categories: International Policy Issues, Prevalence, Production and Supply

Trends in the availability and type of drugs sold on the internet via cryptomarkets, June 2021 – May 2022

5th August 2022

This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period (a new bulletin is released typically every 4 months). The current bulletin focuses on analysis of drug listings on cryptomarkets from 1st June 2021 to 31st May 2022 (NDARC)

Categories: Bibliography, Prevalence

Categories: Prevalence

Deaths related to drug poisoning in England and Wales: 2021 registrations

3rd August 2022

Deaths related to drug poisoning in England and Wales from 1993 to 2021, by cause of death, sex, age and substances involved in the death (Office of National Statistics)

Categories: Bibliography, Prevalence

Categories: Prevalence

The Global Cannabis Cultivation Research Consortium (GCCRC): a transnational online survey of cannabis growers

29th July 2022

This paper presents some of the key findings of an innovative online survey of cannabis growers in Europe, Australia and North America. The International Cannabis Cultivation Questionnaire (ICCQ) present generated important findings about cannabis cultivation, along with policy insights and methodological lessons that would likely have been unattainable through other methods (EMCDDA)

Categories: Bibliography, Prevalence, Production and Supply

Categories: Prevalence, Production and Supply

Drug-related Deaths in Scotland in 2021

28th July 2022

Statistics of drug-related deaths in 2021 and earlier years, broken down by age, sex, substances implicated in the death, underlying cause of death, and NHS Board and Council areas (National Records of Scotland)

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Urban–Rural Differences in Drug Overdose Death Rates, 2020

21st July 2022

Drug overdose death rates, which have been rising over the past decade, differ by urban and rural counties across the United States (CDC)

Categories: Bibliography, Prevalence

Categories: Prevalence
  • 1
  • 2
  • 3
  • …
  • 16
  • Next Page »

Search the Bibliography

Bibliography Menu

  • Introduction
  • All Publications
  • Prevalence
  • Production and Supply
  • Economics
  • Domestic Policy Issues
  • International Policy Issues
  • Interventions – Prevention
  • Interventions – Treatment
  • Interventions – Law Enforcement
  • Interventions – Harm Reduction

Navigation

  • Home
  • Future Conferences & Events
  • News & Announcements
  • Bibliography
  • Working Group
  • Annual Awards
  • Membership
  • Who we are
  • By-laws
  • IJDP
  • Contact

ISSDP on Bluesky

Join us on Bluesky

Contact ISSDP

For further information about the ISSDP, including membership queries, please contact us.

Please Share ISSDP

Copyright © 2025 The International Society for the Study of Drug Policy

The International Society for the Study of Drug Policy is registered in England as a charitable incorporated organisation. Charity no: 1177654